Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc’s blockbuster Tagrisso in a ...

A couple from a small town outside Peoria celebrated their first Christmas with their new baby after a scary cancer diagnosis ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

Abenacianine, a tumor-targeted fluorescent imaging agent, received fast track designation from the FDA after demonstrating ...

Results from the Mariposa study found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced lung ...

Medical experts in the UK have discovered two lesser-known symptoms of lung cancer. These symptoms are finger clubbing and ...

Jan. 6, 2025 — Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer ... Scientists Develop Scans That Light-Up Aggressive ...

The melding of visual information (microscopic and X-ray images, CT and MRI scans, for example) with text (exam notes, communications between physicians of varying specialties) is a key component of ...

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

Zinc Deficiency Promotes Acinetobacter Lung Infection ... immune mechanism in mice that stops escaped cancer cells from developing into tumors elsewhere in the ... Drug Improves Effectiveness ...

Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Non-Small Cell Lung Cancer.